Dentsply Sirona and Siemens Healthineers have achieved FDA clearance for the first dental-specific MRI system — the MAGNETOM Free.Max Dental Edition. The device has been validated for use in endodontics, periodontics, TMJ disorders, extractions, and orthodontics, offering soft-tissue imaging capabilities that complement traditional cone-beam computed tomography (CBCT). This marks the first time MRI technology has been specifically designed and cleared for routine dental diagnostic use, potentially adding a new dimension to dental imaging beyond the current X-ray and CBCT standard of care.

Dental imaging has been dominated by two-dimensional radiography and, more recently, CBCT for three-dimensional hard-tissue visualization. The gap has always been soft tissue — CBCT excels at bone and tooth structure but cannot image muscles, nerves, ligaments, or vascular structures with the detail that MRI provides. For TMJ disorders alone, which affect an estimated 10 million Americans, clinicians have historically needed to refer patients to hospital-based MRI facilities, creating delays, additional costs, and fragmented care. A dental-specific MRI housed in an office or imaging center collapses that referral chain. The Dentsply-Siemens partnership is strategically significant: Dentsply brings the largest dental equipment distribution network globally, while Siemens brings MRI engineering expertise.

For dental practices and DSOs, this technology creates both opportunity and challenge. Practices that adopt dental MRI early could differentiate on diagnostic capability, particularly in endodontics (visualizing periapical pathology in soft tissue), periodontics (assessing soft-tissue attachment loss), and oral surgery (nerve mapping before extractions). However, the capital cost of MRI — even a compact system — will likely be substantially higher than CBCT units ($100K-$250K range), making it more realistic for multi-location DSOs, oral surgery groups, or shared imaging centers than solo practices. Insurance coverage and reimbursement codes will need to catch up before widespread adoption is economically viable.

Watch for how quickly the ADA develops coding and reimbursement guidelines for dental MRI procedures. Without CDT codes and payer acceptance, clinical utility alone won't drive adoption. Monitor whether competing imaging companies (Planmeca, Carestream, KaVo Kerr) respond with their own MRI partnerships or acquisitions. The DSO implications are significant — large platforms with capital access could deploy dental MRI as a competitive moat, further widening the technology gap with independent practices.